Resistance, resistant (to) - in the ICD-10-CM Index

Browse the ICD-10-CM codes with references applicable to the clinical term "resistance, resistant (to)"

• Resistance, resistant (to)

  • activated protein C - D68.51 Activated protein C resistance

  • insulin - E88.819 Insulin resistance, unspecified

    • complicating pregnancy - O26.89 Other specified pregnancy related conditions

    • specified type NEC - E88.818 Other insulin resistance

  • organism (s)

    • to

      • drug - Z16.30 Resistance to unspecified antimicrobial drugs

        • aminoglycosides - Z16.29 Resistance to other single specified antibiotic

        • amoxicillin - Z16.11 Resistance to penicillins

        • ampicillin - Z16.11 Resistance to penicillins

        • antibiotic (s) - Z16.20 Resistance to unspecified antibiotic

          • multiple - Z16.24 Resistance to multiple antibiotics

          • specified NEC - Z16.29 Resistance to other single specified antibiotic

        • antifungal - Z16.32 Resistance to antifungal drug(s)

        • antimicrobial (single) - Z16.30 Resistance to unspecified antimicrobial drugs

          • multiple - Z16.35 Resistance to multiple antimicrobial drugs

          • specified NEC - Z16.39 Resistance to other specified antimicrobial drug

        • antimycobacterial (single) - Z16.341 Resistance to single antimycobacterial drug

          • multiple - Z16.342 Resistance to multiple antimycobacterial drugs

        • antiparasitic - Z16.31 Resistance to antiparasitic drug(s)

        • antiviral - Z16.33 Resistance to antiviral drug(s)

        • beta lactam antibiotics - Z16.10 Resistance to unspecified beta lactam antibiotics

          • specified NEC - Z16.19 Resistance to other specified beta lactam antibiotics

        • carbapenem - Z16.13 Resistance to carbapenem

        • cephalosporins - Z16.19 Resistance to other specified beta lactam antibiotics

        • extended beta lactamase (ESBL) - Z16.12 Extended spectrum beta lactamase (ESBL) resistance

        • fluoroquinolones - Z16.23 Resistance to quinolones and fluoroquinolones

        • macrolides - Z16.29 Resistance to other single specified antibiotic

        • methicillin - See: MRSA;

        • multiple drugs (MDRO)

          • antibiotics - Z16.24 Resistance to multiple antibiotics

          • antimicrobial - Z16.35 Resistance to multiple antimicrobial drugs

          • antimycobacterials - Z16.342 Resistance to multiple antimycobacterial drugs

        • penicillins - Z16.11 Resistance to penicillins

        • quinine (and related compounds) - Z16.31 Resistance to antiparasitic drug(s)

        • quinolones - Z16.23 Resistance to quinolones and fluoroquinolones

        • sulfonamides - Z16.29 Resistance to other single specified antibiotic

        • tetracyclines - Z16.29 Resistance to other single specified antibiotic

        • tuberculostatics (single) - Z16.341 Resistance to single antimycobacterial drug

          • multiple - Z16.342 Resistance to multiple antimycobacterial drugs

        • vancomycin - Z16.21 Resistance to vancomycin

          • related antibiotics - Z16.22 Resistance to vancomycin related antibiotics

  • thyroid hormone - E07.89 Other specified disorders of thyroid

Insulin: A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).